Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
25 May, 2018 21:48 IST
Aurobindo Pharma gets USFDA nod for anti-cough tablets
Source: IRIS | 21 Mar, 2017, 09.14AM
Comments  |  Post Comment

Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30 mg and 1200/60mg (OTC). Aurobindo's Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets are the AB rated generic equivalent of Reckitt Benckiser's Mucinex DM tablets. The product will be launched in Q1FY18.

Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions, making coughs more productive. The approved product has an estimated market size of US$ 235 million for the twelve months ending December 2016 according to IRI database.

This is the 106 th ANDA (including 21 tentative approvals) approved out of Unit VII formulation facility in Hyderabad, India used for manufacturing oral products. Aurobindo now has a total of 311 ANDA approvals (272 Final approvals including 16 from Aurolife Pharma LLC and 39 tentative approvals) from USFDA.

Shares of the company gained Rs 1.7, or 0.24%, to trade at Rs 704.90. The total volume of shares traded was 0 at the BSE (9.01 a.m., Tuesday).



Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Sun Pharmaceutical Industries quarterly earnings up 7% - 25-May-2018 16:12
Tech Mahindra quarterly profit zooms 2.09 times to Rs 12.31 bn - 25-May-2018 16:02
Lupin submits MAA for Etanercept Biosimilar in Europe - 25-May-2018 12:35
HDFC Sec maintains 'Buy' on Granules India - 25-May-2018 11:37
Zydus Cadila gets USFDA nod for Dutasteride, Tamsulosin HCl capsules - 25-May-2018 11:05
Pidilite Industries quarterly earnings surge 57.43% - 25-May-2018 10:34
United Breweries quarterly earnings soar 13.51 times - 25-May-2018 10:23
Larsen & Tubro bags order worth Rs 31.91 bn - 25-May-2018 09:57
MCX strengthens precious metals suite with launch of silver options - 24-May-2018 17:54
Granules India quarterly earnings plummet 55% - 24-May-2018 17:04
GAIL (India) quarterly profit zooms 3.92 times - 24-May-2018 16:58
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer